The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
A randomized, double-blind, placebo-controlled trial of St John’s wort for treating irritable bowel syndrome
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, in a 12-week randomized double-blind, placebo-controlled trial, SJW (450 mg twice daily per os) showed lower efficacy than placebo in treating IBS symptoms (p = 0.03) [81].”
From Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines (2026) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AGA technical review on irritable bowel syndrome.
Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37095 · Cited by 1,384
Patrick, D. L., Drossman, D. A., Frederick, I. O., Dicesare, J., & Puder, K. L. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018831127942 · Cited by 761
Medical costs in community subjects with irritable bowel syndrome
Talley, N. J., Gabriel, S. E., Harmsen, W. S., Zinsmeister, A. R., & Evans, R. W. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90738-6 · Cited by 460 · cited 1×
“IBS carries a considerable cost for both society and patients (”
BackgroundSelf-citationGender differences in irritable bowel syndrome
Chang, L., & Heitkemper, M. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.36603 · Cited by 351
Haringsma, R., Engels, G. I., Beekman, A. T. F., & Spinhoven, P. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1130 · Cited by 299 · cited 1×
“The CES-D is a well-validated, self-administered 20-item instrument that measures depression symptoms (”
Dorn, S. D., Kaptchuk, T. J., Park, J. B., Nguyen, L. T., Canenguez, K., Nam, B. H., Woods, K. B., Conboy, L. A., Stason, W. B., & Lembo, A. J. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.00937.x · Cited by 119
Research works printed but not linked: 32
- Saito, 2002, The epidemiology of irritable bowel syndrome in North America: a systematic review., Am J Gastroenterol, 97, 1910
- El-Serag, 2002, Health-related quality of life among persons with irritable bowel syndrome: a systematic review., Aliment Pharmacol Ther, 16, 1171, 10.1046/j.1365-2036.2002.01290.x · DOI
- Donker, 1999, Patients with irritable bowel syndrome: health status and use of health care services., Br J Gen Pract, 49, 787
- Vandvik, 2006, Prevalence, comorbidity and impact of irritable bowel syndrome in Norway., Scand J Gastroenterol, 41, 650, 10.1080/00365520500442542 · DOI
- van Tilburg, 2008, Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO., BMC Complement Altern Med, 8, 46, 10.1186/1472-6882-8-46 · DOI
- Koloski, 2003, Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia., Aliment Pharmacol Ther, 17, 841, 10.1046/j.1365-2036.2003.01498.x · DOI
- Carmona-Sanchez, 2005, Prevalence of use of alternative and complementary medicine in patients with irritable bowel syndrome, functional dyspepsia and gastroesophageal reflux disease., Rev Gastroenterol Mex, 70, 393
- Jarrett, 1999, Alternative health care practices in women with irritable bowel syndrome., Gastroenterology, 116, A1012
- Smart, 1986, Alternative medicine consultations and remedies in patients with the irritable bowel syndrome., Gut, 27, 826, 10.1136/gut.27.7.826 · DOI
- Kong, 2005, The incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases., J Clin Gastroenterol, 39, 138
- Pittler, 1998, Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis. Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial., Am J Gastroenterol, 93, 1131, 10.1111/j.1572-0241.1998.00343.x · DOI · Paper page
- Bensoussan, 1998, Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial., JAMA, 280, 1585, 10.1001/jama.280.18.1585 · DOI · Paper page
- Bundy, 2004, Artichoke leaf extract reduces symptoms of irritable bowel syndrome and improves quality of life in otherwise healthy volunteers suffering from concomitant dyspepsia: a subset analysis., J Altern Complement Med, 10, 667, 10.1089/acm.2004.10.667 · DOI
- Masand, 1995, Major depression and irritable bowel syndrome: is there a relationship?, J Clin Psychiatry, 56, 363
- Muller, 1994, Effects of hypericum extract on the expression of serotonin receptors., J Geriatr Psychiatry Neurol, 7, S63, 10.1177/089198879400700117 · DOI
- Neary, 1999, Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes., Brain Res, 816, 358, 10.1016/S0006-8993(98)01126-3 · DOI
- Franklin, 1999, Neuroendocrine evidence for dopaminergic actions of hypericum extract (LI 160) in healthy volunteers., Biol Psychiatry, 46, 581, 10.1016/S0006-3223(99)00102-X · DOI
- Gobbi, 1999, Hypericum perforatum L. extract does not inhibit 5-HT1 transporter in rat brain cortex., Naunyn-Schmiedebergs Arch Pharmacol, 360, 262, 10.1007/s002109900073 · DOI
- Teufel-Mayer, 1997, Effects of long-term administration of hypericum extracts on the affinity and density of the central serotonergic 5-HT1 A and 5-HT2 A receptors., Pharmacopsychiatry, 30, 113, 10.1055/s-2007-979530 · DOI
- Yu, 2000, Effect of the Hypericum perforatum extract on serotonin turnover in the mouse brain., Pharmacopsychiatry, 33, 60, 10.1055/s-2000-7970 · DOI
- Gershon, 2007, The serotonin signaling system: from basic understanding to drug development for functional GI disorders., Gastroenterology, 132, 397, 10.1053/j.gastro.2006.11.002 · DOI · Paper page
- Jackson, 2000, Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis., Am J Med, 108, 65, 10.1016/S0002-9343(99)00299-5 · DOI · Paper page
- Tack, 2005, A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation., Gut, 54, 1707, 10.1136/gut.2005.070789 · DOI
- Rahimi, 2008, Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials., Clin Ther, 30, 884, 10.1016/j.clinthera.2008.05.002 · DOI
- Bijkerk, 2003, Outcome measures in irritable bowel syndrome: comparison of psychometric and methodological characteristics., Am J Gastroenterol, 98, 122, 10.1111/j.1572-0241.2003.07158.x · DOI
- Drossman, 2000, Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire., Am J Gastroenterol, 95, 999, 10.1111/j.1572-0241.2000.01941.x · DOI · Paper page
- Sallon, 2002, A novel treatment for constipation-predominant irritable bowel syndrome using Padma Lax, a Tibetan herbal formula., Digestion, 65, 161, 10.1159/000064936 · DOI
- Madisch, 2004, Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial., Aliment Pharmacol Ther, 19, 271, 10.1111/j.1365-2036.2004.01859.x · DOI · Paper page
- Brinkhaus, 2005, Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: a randomized, placebo-controlled, double-blind clinical trial., Scand J Gastroenterol, 40, 936, 10.1080/00365520510023134 · DOI · Paper page
- Leung, 2006, Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial., Am J Gastroenterol, 101, 1574, 10.1111/j.1572-0241.2006.00576.x · DOI
- Davis, 2006, Randomised double-blind placebo-controlled trial of aloe vera for irritable bowel syndrome., Int J Clin Pract, 60, 1080, 10.1111/j.1742-1241.2006.00980.x · DOI
- Szegedi, 2005, Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St Johns wort): randomised controlled double blind non-inferiority trial versus paroxetine. see commenterratum appears in BMJ. 2005 Apr 2; 330 (7494):759 Note: dosage error in text., BMJ, 330, 503, 10.1136/bmj.38356.655266.82 · DOI
Cited by
Pharmacologic and Complementary and Alternative Medicine Therapies for Irritable Bowel Syndrome
Chey, W. D., Maneerattaporn, M., & Saad, R. (2011) · Gut and Liver · doi:10.5009/gnl.2011.5.3.253 · Cited by 89
Schmulson, M., & Chang, L. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04637.x · Cited by 70
Pastras, P., Aggeletopoulou, I., Bali, M., & Triantos, C. (2026) · Nutrients · doi:10.3390/nu18020183 · Cited by 1
Metadata
- Authors
- Saito, Y. A., Rey, E., Almazar-Elder, A. E., Harmsen, S. W., Zinsmeister, A. R., Locke, R. G., & Talley, N. J.
- Venue
- American Journal of Gastroenterology
- Published
- 2010-01
- Volume
- 105
- Issue
- 1
- Pages
- 170-177
- ISSN
- 0002-9270
- Cited by
- 39
- References
- 6
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A randomized, double-blind, placebo-controlled trial of St John’s wort for treating irritable bowel syndrome. https://app.cochat.ai/papers/10.1038/ajg.2009.577
- The paper
- Saito, Y. A., Rey, E., Almazar-Elder, A. E., Harmsen, S. W., Zinsmeister, A. R., Locke, R. G., & Talley, N. J. (2010). A randomized, double-blind, placebo-controlled trial of St John’s wort for treating irritable bowel syndrome. American Journal of Gastroenterology. https://doi.org/10.1038/ajg.2009.577
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.